Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H RUEL

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|January 20, 2007
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapyVania Kenanova, Tove Olafsen, Lawrence E Williams, et al.
European Urology|June 19, 2012
Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomyBertram E Yuh, Michael Nazmy, Nora H Ruel, et al.
Therapeutic Advances in Urology|May 7, 2019
Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomyJim K Shen, Juzar Jamnagerwalla, Bertram E Yuh, et al.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
Cancer Research Communications|July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
Plos One|May 25, 2012
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosisXiwei Wu, Lihong Weng, Xuejun Li, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|January 20, 2007
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapyVania Kenanova, Tove Olafsen, Lawrence E Williams, et al.
European Urology|June 19, 2012
Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomyBertram E Yuh, Michael Nazmy, Nora H Ruel, et al.
Therapeutic Advances in Urology|May 7, 2019
Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomyJim K Shen, Juzar Jamnagerwalla, Bertram E Yuh, et al.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
Cancer Research Communications|July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
Plos One|May 25, 2012
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosisXiwei Wu, Lihong Weng, Xuejun Li, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Pageof 5